Archive

Post Written By Gunjan Bhardwaj   Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG.     The cost of drug development has skyrocketed, but disruptive technologies can bring it back down to earth.   Over the past several decades, drug-development costs have risen significantly, from $250 million per approved drug prior to the 1990s to $403 million in the 2000s and $873 million in 2010 ($1.778 billion if capitalization...

Read More

  Insights into the Third Wave of Artificial intelligence promises the first AI Summit organised by Innoplexus and Frankfurt School of Finance & Management   On June 18, 2018, the first annual AI summit jointly organised by Frankfurt School of Finance & Management and Innoplexus will take place at the campus of Frankfurt School.   Among other activities, Frankfurt School with its AI Initiative establishes a Research Centre, the Academic Programme Master in...

Read More

  Nobody doubts that fake medicines are an increasing threat to consumers and the pharma industry’s bottom line. Is blockchain the answer to secure the supply chain?   Counterfeit medicines are a multi-billion dollar problem on a global level. From the size, shape and colour of the pharmaceuticals, to the packaging made to look like the real thing, these bogus products usually contain small amounts of the active...

Read More

  Medicine is ripe for disruption. As David Lawrence, former Chairman and CEO of the Kaiser Foundation Health Plan, wrote in his 2005 book chapter Bridging the Quality Chasm: “Between $.30 and $.40 of every dollar spent on healthcare is spent on the costs of poor quality. This extraordinary number represents slightly more than a half-trillion dollars a year. A vast amount of money is wasted on overuse,...

Read More

  The entire pharmaceutical industry has been booming, from the manufacturing of clinical trial materials to support research studies to the regulated medicines on the pharmacy shelves. It has been one of the top industry performers of the past three decades.   By maintaining the highest safety and quality standards, many pharma business units along the supply chain, such as research and development materials, manufacturing, sales and marketing,...

Read More

  In the 21st century pharma companies face novel challenges. Pairing artificial intelligence (AI) capabilities with human strengths can bring a competitive edge in this rapidly–changing world.   As the Nobel-prize-winning economist Daniel Kahneman wrote in his book Thinking, Fast and Slow, “Intelligence is not only the ability to reason; it is also the ability to find relevant material in memory and to deploy attention when needed.”     Current Artificial Intelligence...

Read More

  When medicine incorporates AI, blockchain, and big data we are going to lower costs, reduce health disparity, and speed novel therapeutics to market.   As Ginny Rometti, the current CEO of IBM and also the first woman to head the company is quoted as saying: “Some people call this artificial intelligence, but the reality is this technology will enhance us. So instead of artificial intelligence, I think...

Read More

  The effectiveness of AI applications can be undermined by the volumes of unstructured data prevalent in the pharma industry. What can be done to overcome this issue?    We live in an exciting time for the pharmaceutical industry. Cutting-edge technologies like artificial intelligence (AI) and Blockchain are making headlines or revolutionising everything from drug discovery to clinical trials. Many of these innovations are built upon the same...

Read More

  Cutting-edge technologies are increasingly improving pharma’s R&D processes, which will reduce costs and, in turn, benefit patients, says Gunjan Bhardwaj.   It’s no secret that drug prices are a controversial issue. Just last week, US President Trump called high drug prices an “injustice” and vowed to make the issue a priority for his administration.   In the face of such pressure, pharmaceutical companies are eager to reduce the cost...

Read More

Post Written By Gunjan Bhardwaj   Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG.   I recently wrote about five technologies that are shaping the future of healthcare. One of these technologies — artificial intelligence — holds particular potential for improving medical care at the clinical level.   Thanks to the digital revolution, medical professionals don’t have to memorize nearly as much information as they did...

Read More
Book a Demo Book a Demo